Molecular epidemiology of endemic Clostridium difficile infection by Fawley, W.N. & Wilcox, M.H.
Epidemiol. Infect. (2001), 126, 343–350. Printed in the United Kingdom # 2001 Cambridge University Press
Molecular epidemiology of endemic Clostridium difficile
infection
W. N. FAWLEY and M. H. WILCOX*
Department of Microbiology, Leeds General infirmary and Uniersity of Leeds, Leeds LS1 3EX, UK
(Accepted 21 January 2001)
SUMMARY
This is the first study to provide a comprehensive insight into the molecular epidemiology of
endemic Clostridium difficile and particularly that associated with a recently recognized
epidemic strain. We DNA fingerprinted all C. difficile isolates from the stools of patients with
symptomatic antibiotic-associated diarrhoea and from repeated samples of the inanimate ward
environment on two elderly medicine hospital wards over a 22-month period. Notably, C.
difficile was not recoverable from either ward immediately before opening, but was found on
both wards within 1–3 weeks of opening, and the level of environmental contamination rose
markedly during the first 6 months of the study period. C. difficile infection (CDI) incidence
data correlated significantly with the prevalence of environmental C. difficile on ward B
(rfl 0–76, P! 0–05) but not on ward A (rfl 0–26, P" 0–05). We found that RAPD and
RS–PCR typing had similar discriminatory power, although, despite fingerprinting over 200
C. difficile isolates, we identified only six distinct types. Only two distinct C. difficile strains
were identified as causing both patient infection and ward contamination. Attempts to
determine whether infected patients or contaminated environments are the prime source for
cross-infection by C. difficile had limited success, as over 90% of C. difficile isolates were the
UK epidemic clone. However, a non-epidemic strain caused a cluster of six cases of CDI, but
was only isolated from the environment after the sixth patient became symptomatic. The initial
absence of this strain from the environment implies patient-to-patient and}or staff-to-patient
spread. In general, routine cleaning with detergent was unsuccessful at removing C. difficile
from the environment. Understanding the epidemiology and virulence of prevalent strains is
important if CDI is to be successfully controlled.
INTRODUCTION
Clostridium difficile is the prime pathogen causing
antibiotic associated diarrhoea and colitis particularly
in the hospital setting [1–4]. While it has been
established that certain antibiotics, notably second
and third generation cephalosporins have a high
propensity to cause C. difficile infection (CDI) [2, 5], it
is important that exposure of hospitalized patients to
sources of C. difficile is minimized. This has become
* Author for correspondence.
increasingly difficult on hospital wards where sus-
ceptible patients share the same living space as C.
difficile infected individuals. Clusters of cases of
nosocomial CDI have been reported in a variety of
hospital units, including geriatric and surgical wards,
and intensive care and transplantation units [6].
Contaminated environmental surfaces and health-
care personnel hand carriage are considered as
important sources for C. difficile transmission in
hospitals [6]. Bacterial spores have been found in far
greater quantities in the environment around indi-
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viduals with CDI in comparison with asympto-
matically colonized patients, presumably secondary to
diarrhoea, which can often be unexpected and
explosive, so increasing shedding of C. difficile [7]. C.
difficile spores are highly resistant to many commonly
used disinfectants and may persist for many months in
hospital ward environments [8]. Additionally, it has
been shown that the frequency of C. difficile positive
healthcare personnel hand cultures was highly corre-
lated with the intensity of environmental contami-
nation [9]. The true significance of the environment as
a potential reservoir for C. difficile and its role in
subsequent patient infection remains unclear, pri-
marily because it has proven difficult to determine
whether environmental contamination is a cause or
consequence of diarrhoea. Studies to date have been
limited, however, in that they studied environmental
contamination either only as a point prevalence rate
or over a short period of time (! 6 months).
Molecular epidemiologic analysis of C. difficile
isolates collected from geographically distinct
hospitals throughout the United Kingdom has demon-
strated the presence of a single predominant strain,
suggesting the possibility that some strains have a
greater propensity for nosocomial transmission [10].
We have previously reported that this epidemic strain
was responsible for 75–80% of CDIs encountered as
part of a prospective ward crossover study examining
antibiotic-related C. difficile risk [11]. Elderly in-
patients are most closely associated with CDI, yet few
reports have studied the epidemiology of C. difficile
amongst hospitalized patients in non-outbreak
situations. Therefore, we prospectively studied all C.
difficile isolates recovered from symptomatic patients
and from repeated environmental sampling on two
elderly medicine hospital wards over a 22-month
period, from their opening to a planned move. We
aimed to investigate the molecular epidemiology of
endemic C. difficile infection, particularly that
associated with the UK epidemic strain, and to
explore the relationship between environmental con-
tamination and patient infection.
MATERIALS AND METHODS
Study design
We DNA fingerprinted all C. difficile isolates from the
stools of patients with symptomatic antibiotic
associated diarrhoea and from systematically collected
samples of the inanimate ward environment on two
elderly medicine hospital wards over a 22-month
period, from ward opening to a planned move, during
the period October 1995 to July 1997. The study
wards were of similar design, each consisting of four
six-bedded bays and containing four side rooms, and
were situated on the same floor of a 10-year-old-
building.
C. difficile infection diagnosis, culture and
identification
Faecal samples were tested for the presence of C.
difficile cytotoxin on request in the routine diagnostic
laboratory from patients with diarrhoea suspected to
be due to C. difficile. Cytotoxin was detected by a
microtitre tray method using Hep-2 cells with
Clostridium sordellii protected controls, and a 1 in 50
final dilution of faeces in cell culture medium.
Cytotoxin positive faeces were stored at fi20 °C
pending culture for C. difficile.
Environmental sampling was performed monthly.
Sites were sampled in a systematic manner (10‹10 cm
areas) with sterile cotton wool swabs moistened with
0–25% Ringer’s solution (Oxoid, Basingstoke, UK),
and then cultured immediately for C. difficile. C.
difficile isolates were recovered from environmental
and frozen faecal samples by culture on cycloserine
cefoxitin supplemented agar without egg yolk
(modified CCEY; Lab M Bury, UK) for 48 h in an
anaerobic cabinet at 37 °C. After direct inoculation
onto modified CCEY, environmental swabs were
incubated anaerobically in Robertson’s cooked meat
broth for 48 h at 37 °C. Resultant broth cultures were
then inoculated onto modified CCEY medium as
before. All C. difficile isolates were recognized by their
characteristic colonial morphology and odour, and in
cases of doubt, RaplD ANA II System (Innovative
Diagnostic Systems, GA, USA) was used. All C.
difficile strains were stored in PBS}glycerol solution at
fi20 °C.
DNA fingerprinting
DNA fingerprinting of C. difficile isolates was per-
formed using both random amplified polymorphic
DNA (RAPD) and ribospacer polymerase chain
reaction (RS–PCR) techniques in order to maximize
the chance of discriminating between strains. Target
DNA was extracted from each bacterial strain as
previously described [12]. To detect any mixed cultures
of C. difficile, separate typing reactions were per-
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formed on DNA samples extracted from both single
and multiple colonies.
RAPD primer ARB11 [13] (5«-CTA GGA CCGC-
3«) and RS–PCR primers [14] L1 (5«-CAA GGC ATC
CAC CGT-5«) and G1 (5«-GAA GTC GTA ACA
AGG-3«), (all obtained from the Oligonucleotide
Synthesis Service, Institute of Pathology, University
of Leeds, UK) were used in the study. The following
were added to each 25 ll reaction volume: 5 ll PCR
buffer (‹10 concentrate, BioLine), 8 ll of deoxy-
nucleoside triphosphate premix (1–25 mm each dNTP)
(Pharmacia & Upjohn Inc, Herts, UK), 0–5 ll
BioExtract taq polymerase (2 units}reaction, BioLine,
UK), and 3 ll DNA extract. For RAPD, 0–5 ll
ARB11 primer (40 pmol) and 2 ll of 50 mm MgCl
#
(final concentration 4 mm) were added to the reaction
mixture. For RS–PCR, 0–25 ll L1}G1 premix
(25 pmol) and 2–25 ll of 50 mm MgCl
#
(final con-
centration 5–5 mm) were added. DNA amplification
was carried out in an Ericomp Twinblock
EasyCyclerTM (Lazer Laboratory Systems,
Southampton, UK). RAPD reactions were subjected
to 35 cycles, each lasting 1 min at 94 °C, 1 min at
36 °C and 2 min at 72 °C, whereas RS–PCR reactions
were subjected to 34 cycles, each lasting 1 min at
94 °C, 1 min at 45 °C and 1 min at 72 °C. Amplified
DNA was separated by agarose gel electrophoresis
using Tris–borate EDTA (TBE) buffer pH 8–0 and
2% MetaphorTM gels (Flowgen, Staffs, UK) for 4 h at
180 V}180 mA. DNA fingerprints were visualized,
after ethidium bromide staining, with an
ImageMasterTM VDS camera (Pharmacia & UpJohn
Inc, Herts).
RESULTS
C. difficile strains recovered from patients
During the study period there were 125 separate cases
of CDI defined by routine diagnostic testing, 55 cases
on ward A and 70 cases on ward B. Specimens from
patients with recurrent diarrhoea were excluded. This
corresponded to CDI incidences of 9–2 and 8–9 cases
per 100 patient admissions for wards A and B,
respectively. C. difficile was successfully cultured from
86.4% of stored faecal samples, providing 108 strains
for DNA fingerprinting.
After visual comparison of DNA fingerprints,
isolates that differed by three or more DNA fragments
from other strains typed by RAPD were assigned to a
new typing group. RAPD based on primer ARB11
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Fig. 1. Summary of DNA fingerprints from C. difficile
isolates from both patients and the environment on wards A
and B using RAPD–PCR technique (a) and RS–PCR
technique (b). Prints from ethidium bromide stained 2%
MetaphorTM agarose gels are shown. Assigned genotypes
are indicated at bottom of lanes. On both gels : lane
6:100 bp ladder ; lane 10: negative PCR control.
successfully separated 108 strains into four distinct
types (Fig. 1). Strains typed by RS–PCR were
considered distinguishable if " 2 inter-strain band
differences were present [15]. This method was found
to have an equivalent discriminatory power to RAPD,
separating the 108 strains into the same four groups.
On ward A, only two genotypes were found (I and II).
Apart from one isolate (genotype II), all strains
originating from ward A were genotype I (Table 1).
On ward B, only three genotypes were discovered (I,
III and IV), and genotype I represented 87% of all
patient isolates examined.
C. difficile strains recovered from ward environments
Over the 22-month study period, 1122 swabs were
taken from pre-defined environmental sites, 572 on
ward A and 550 from ward B. The sites sampled
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Table 1. C. difficile genotypes isolated from patients and their enironment on study wards A and B
Clinical isolates
Environmental isolates
Ward Genotype (number of isolates) Number of isolates Environmental site
A I 47}48 40}43 Endemic
II 1}48 NI NA
V NI* 1}43 Commodes
VI NI 1}43 Radiators
VII NI 1}43 Toilet floor
B I 52}60 55}60 Endemic
III 1}60 4}60 Toilet floor}air vents
IV 7}60 NI NA
VIII NI 1}60 Sluice floor
* NI, Not isolated; NA, not applicable.
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Fig. 2. Frequency of C. difficile culture positive environmental sites on study wards A and B. +, ward A; P, ward B.
comprised radiators (16%), air vents (16%),
commodes (16%) and floors (52%) from wards,
toilets and sluice rooms. Overall, 34 and 36% of sites
were C. difficile culture positive on wards A and B,
respectively. C. difficile was most frequently cultured
from commodes and toilet}sluice room floors (Fig. 2).
ln total, only 21 (6–8%) sites were positive when swabs
were cultured on modified CCEY medium alone, the
majority (85.7%) of which yielded ! 5 bacterial
colonies. When swabs were enriched by culture in
Robertson’s cooked meat broth, total recovery was
increased markedly (35–1% of sites were found to be
C. difficile positive). Five strains were unrecoverable
after freezer storage, leaving 103 environmental
isolates available for DNA fingerprinting.
Both RAPD and RS–PCR techniques separated
103 strains into six distinct groups (Fig. 1). Ninety-five
isolates from both wards were indistinguishable from
the patient genotype I strain; 92 and 94% of total
isolates from wards A and B, respectively (Table 1).
Three other genotypes were found on ward A
(genotypes V, VI and VII), and two on ward B
(genotypes IV and VIII). Other than genotypes I and
IV, environmental strains were isolated only once,
and were dissimilar from any patient isolates. Also,
two environmental strains were non-toxin producers
(genotypes V and VI). Genotype I was the only strain
present on both study wards. Apart from this endemic
strain, genotype IV was the only strain implicated in
both patient infection and ward environmental con-
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Fig. 3. Quarterly figures : CDI and environmental culture
positivity for study wards A (a) and B (b). +, Patient
isolates ; E, environmental isolates.
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Fig. 4. Recovery of C. difficile from environmental sites on
wards A (a) and B (b) during months 0–6. › indicates at
least one of the samples from site type was C. difficile
positive.
tamination. Genotype IV was the only example of a
C. difficile type that was recovered from the en-
vironment after, but not before, isolation from six
symptomatic patients.
CDI and ward environmental contamination
Quarterly figures for CDI and environmental culture
positivity for wards A and B are shown in Figure 3.
CDI incidence data correlated significantly with the
prevalence of environmental C. difficile on ward B
(rfl 0–76, P! 0–05) but not on ward A (rfl 0–26;
P" 0–05). Figure 4 shows the month-by-month
increases in the numbers of environmental site types
on the study wards that were C. difficile culture
positive during the first 6 months of the study. C.
difficile was not isolated from the environment of
either ward before opening, but was found from both
wards within 1–3 weeks of opening.
DISCUSSION
We are aware of only one previous study [9] that
systematically examined the relationship between
environmental contamination and CDI. Samore and
colleagues documented marked environmental con-
tamination and transmission to personnel and patient
contacts by an endemic C. difficile strain over a 6-
month period [9]. Several studies have documented
the presence of C. difficile spores in areas occupied by
infected patients, but these have been over short time
periods, and evidence of bacterial acquisition from
exposure to contaminated environmental sources is
scarce. One study concluded that disparate strains
responsible for causing disease were more likely to
have originated from an environmental source than
from cross-infection from patient to patient [16].
Elsewhere, a cluster of CDls on a surgical unit was
associated with an identical strain found in the
environment [17]. Conversely, Cohen et al. found no
evidence to suggest environmental acquisition of C.
difficile [18].
We found that C. difficile was not recoverable from
either ward immediately before opening. However,
the level of environmental contamination rose mark-
edly during the first 6 months of the study period (Fig.
4). Samore and colleagues found that the frequency of
positive personnel hand culture was strongly corre-
lated with intensity of environmental contamination
[9]. In our study, the incidence of CDI on ward B, but
not on ward A, was strongly correlated with en-
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vironmental contamination levels over the 22-month
testing period (rfl 0–76, P! 0–05). It is interesting to
speculate why such a marked difference in strength of
correlation was found between wards A and B. We are
unaware of marked differences, but several factors not
specifically addressed in this study, including anti-
biotic prescribing practice, patient type and cleaning
efficiency, may have influenced either the incidence of
CDI or environmental contamination. A comparative
trial of CDI risk associated with treatment with
cefotaxime or piperacillin-tazobactam occurred on
these two wards during part of the present study
period [11]. However, this was a ward crossover trial,
and thus effects of antibiotic use on CDI or en-
vironmental contamination should in theory have
been balanced.
Endemic CDI can be controlled by reducing the use
of high risk agents [19–22], However, changes in
incidence of CDI following altered antibiotic pre-
scribing practice have generally been seen in non-
comparative settings, and}or have not been tested by
reintroduction of the suspected antibiotics. Recently,
Stone and Kibbler [23] reported that a fall in incidence
of C. difficile diarrhoea in an elderly medicine unit was
associated with a reduction in cephalosporin use.
Feedback to clinicians on C. difficile rates and
antibiotic prescribing levels was relaxed leading to an
increase in diarrhoea. Following re-enforcement of an
antibiotic policy to limit cephalosporin prescribing, C.
difficile diarrhoea rates reduced again. The purpose of
the present study was not to examine the effects of
intervention in environmental cleaning, but rather to
determine the baseline relationship between C. difficile
contamination levels and CDI. Conventional reaction
to an outbreak of CDI includes enhanced environ-
mental cleaning, and we have reported the success of
this approach [24].
Attempts to determine whether infected patients or
contaminated environments are the prime source for
cross-infection by C. difficile had limited success. Over
90% of C. difficile strains isolated in the study were
the UK epidemic clone (genotype I). This makes
assessment of the interplay of distinct C. difficile
strains between the patient and the hospital ward
difficult. In addition, the undulating frequencies of
both infection and ward contamination remained in
phase and therefore it was not possible to determine
whether patient CDIs preceded a rise in ward
contamination or vice versa. We have shown since this
study was performed that environmental recovery of
C. difficile is markedly increased if lysozyme is
incorporated into the selective agar used for sample
culture [25]. We believe that use of this improved
approach would not have substantially altered the
findings of this study, as we have isolated similar
limited C. difficile types seen here using lysozyme-
containing media (unpublished data). The two DNA
fingerprinting techniques that we employed had
similar discriminatory power. RAPD typing results
correlated fully with those of RS–PCR typing in this
setting, although despite fingerprinting over 200 C.
difficile isolates, we identified only six distinct types.
As expected, RS–PCR technique was found to be
slightly more reproducible than RAPD, given the high
susceptibility of the latter even to very small variations
in testing conditions. DNA fingerprinting by pulsed-
field gel electrophoresis was also examined initially
but was abandoned as it was ineffective in producing
a pulsotype for the endemic clone. DNA from these
strains was repeatedly degraded, presumably by
endonucleases (data not shown), as described by
several other groups [9, 26, 27].
We identifed only two distinct C. difficile strains
that caused both patient infection and ward con-
tamination (RAPD genotypes I and IV). Interestingly,
genotype IV was responsible for a cluster of six cases
of CDI, but was only isolated from the environment
after the sixth patient became symptomatic. The
absence of genotype IV in the environment over this
period implies patient-to-patient and}or staff-to-
patient spread. Genotype IV was initially isolated
from toilet floors on ward B. While contamination
was removed from this area by routine cleaning, it
persisted on air vents for the remainder of the study.
Point prevalence sampling on the study wards 6
months after opening showed that 69 and 40% of
high dust sites were C. difficile positive on wards A
and B, respectively. These observations imply that
routine cleaning does not prevent extensive con-
tamination of high-reach sites. Deep cleaning (high-
reach site decontamination and wall washing) was
performed during the study period on ward B, in
response to an outbreak of gastroenteritis (see Fig. 4,
in between the 5th and 6th data sets). This resulted in
a marked decrease in C. difficile culture-positive sites.
This observation implies C. difficile environmental
persistence may in part be due to sub-optimal routine
cleaning. Routine environmental cleaning on study
wards was carried out using a general-purpose
detergent (containing phosphate and ionic and non-
ionic surfactants), in line with current advice [28].
However, C. difficile genotype I sporulates markedly
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more when exposed to non-chlorine based cleaning
agents compared with chlorine-containing disin-
fectants [29]. Therefore, use of some detergents}
disinfectants may actually be exacerbating environ-
mental persistence of the UK epidemic C. difficile
strain. It has been estimated that each CDI case costs
more than £4000 [30]. This high figure could be used
to justify expenditure on improved standards of
hospital cleanliness [31].
The Anaerobic Reference Unit of the Public Health
Laboratory Service has confirmed the endemic strain
identified here as PCR ribotype 1 (J. Brazier,
personal communication). This strain is known to be
endemic in 33 of 58 hospitals in England and Wales
[32]. It is interesting to speculate on the high
prevalence of this strain in hospitalized patients [10].
Results from the present study suggest a relationship
may exist between CDI incidence and the level of C.
difficile spore contamination in the hospital environ-
ment. Thus, more cases of endemic infection result in
the release of more spores into the environment,
creating the potential for more cases of endemic
infection. However, although several C. difficile strains
were found in the study, only genotype I was
predominant. This implies that strain-specific charac-
teristics have contributed to persistence. This is the
first comprehensive insight into the molecular epi-
demiology of endemic C. difficile, particularly that
associated with a recently recognized epidemic strain,
Understanding the epidemiology and virulence of
prevalent strains is important if CDI is to be
successfully controlled.
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